FERRARI, Silvia Martina
 Distribuzione geografica
Continente #
NA - Nord America 8.650
EU - Europa 2.869
AS - Asia 2.285
SA - Sud America 301
AF - Africa 40
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 5
Totale 14.155
Nazione #
US - Stati Uniti d'America 8.600
GB - Regno Unito 1.570
CN - Cina 772
SG - Singapore 706
HK - Hong Kong 365
SE - Svezia 262
BR - Brasile 251
DE - Germania 229
UA - Ucraina 181
TR - Turchia 172
FI - Finlandia 152
IT - Italia 146
RU - Federazione Russa 116
VN - Vietnam 87
FR - Francia 76
BG - Bulgaria 64
KR - Corea 38
ID - Indonesia 34
AR - Argentina 23
CA - Canada 23
ZA - Sudafrica 23
AE - Emirati Arabi Uniti 18
IN - India 17
NL - Olanda 15
ES - Italia 14
JP - Giappone 13
EC - Ecuador 12
IE - Irlanda 11
PL - Polonia 11
BD - Bangladesh 10
MX - Messico 10
BZ - Belize 9
IQ - Iraq 9
PK - Pakistan 8
MY - Malesia 7
CL - Cile 6
NP - Nepal 6
KE - Kenya 5
AU - Australia 4
CO - Colombia 4
EG - Egitto 4
JO - Giordania 4
LT - Lituania 4
MA - Marocco 4
AZ - Azerbaigian 3
BY - Bielorussia 3
EU - Europa 3
SA - Arabia Saudita 3
TT - Trinidad e Tobago 3
UZ - Uzbekistan 3
VE - Venezuela 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AT - Austria 2
BE - Belgio 2
CH - Svizzera 2
HN - Honduras 2
HU - Ungheria 2
IR - Iran 2
PS - Palestinian Territory 2
RO - Romania 2
TN - Tunisia 2
AM - Armenia 1
BH - Bahrain 1
BO - Bolivia 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
IL - Israele 1
IS - Islanda 1
JM - Giamaica 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MN - Mongolia 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TV - Tuvalu 1
UY - Uruguay 1
ZM - Zambia 1
Totale 14.155
Città #
Southend 1.275
Fairfield 911
Santa Clara 759
Ashburn 595
Woodbridge 589
Chicago 475
Singapore 441
Jacksonville 387
Hong Kong 365
Houston 352
Seattle 334
Los Angeles 304
Chandler 296
Cambridge 282
Wilmington 278
Dearborn 225
Ann Arbor 217
Salt Lake City 205
Hefei 194
Nyköping 184
London 167
Beijing 133
Izmir 113
Helsinki 94
Tampa 94
Elk Grove Village 92
Princeton 70
San Diego 65
Sofia 64
Bremen 62
Modena 60
Eugene 58
Sterling 50
New York 49
Dallas 48
Council Bluffs 47
Lancaster 43
Buffalo 41
Seoul 38
Shanghai 33
The Dalles 33
Moscow 31
Dulles 29
Ho Chi Minh City 29
Miami 29
Columbus 27
Frankfurt am Main 27
Jakarta 27
São Paulo 27
Detroit 26
Des Moines 25
Atlanta 23
Hanoi 23
San Jose 21
Phoenix 18
Redwood City 17
Dong Ket 14
Kansas City 14
Milan 14
Kunming 13
Boardman 12
Guangzhou 12
Norwalk 12
Brooklyn 11
Chiswick 11
Dublin 11
Pittsburgh 11
Warsaw 11
Curitiba 10
Hounslow 10
Tokyo 10
Belize City 9
Hangzhou 9
Kilburn 9
Jersey City 8
Montreal 8
Johannesburg 7
Redondo Beach 7
San Francisco 7
Toronto 7
Belo Horizonte 6
Denver 6
Mountain View 6
Saint Louis 6
Tianjin 6
Acton 5
Amsterdam 5
Baltimore 5
Campinas 5
Chengdu 5
Delhi 5
Falls Church 5
Fuzhou 5
Indiana 5
Jiaxing 5
Jinan 5
Nanjing 5
Quito 5
Rio de Janeiro 5
Serra 5
Totale 10.853
Nome #
Thyroid Involvement in Hepatitis C Virus-Infected Patients with/without Mixed Cryoglobulinemia 740
Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases. 377
Endocrine manifestations of hepatitis C virus infection. 342
Hepatitis C virus infection and type 1 and type 2 diabetes mellitus 342
High values of CXCL10 serum levels in patients with hepatitis C associated mixed cryoglobulinemia in presence or absence of autoimmune thyroiditis 328
CXCL10 (α) and CCL2 (β) chemokines in systemic sclerosis - A longitudinal study 322
Incidence of thyroid disorders in systemic sclerosis: results from a longitudinal follow-up. 320
CXCL10 and CCL2 serum levels in patients with mixed cryoglobulinaemia and hepatitis C. 314
Circulating CXCL11 and CXCL10 are increased in hepatitis C-associated cryoglobulinemia in the presence of autoimmune thyroiditis. 310
High levels of circulating N-terminal pro-brain natriuretic peptide in patients with hepatitis C. 305
IFN-γ and TNF-α induce a different modulation of interleukin-6 in systemic sclerosis fibroblasts compared to healthy controls. 302
High interleukin-6 and tumor necrosis factor-alpha serum levels in hepatitis C infection associated or not with mixed cryoglobulinemia 294
Targeting chemokine (C-X-C motif) receptor 3 in thyroid autoimmunity 283
Chemokines in the pathogenesis and as therapeutical markers and targets of HCV chronic infection, and HCV extrahepatic manifestations 280
High circulating levels of N-terminal pro-brain natriuretic peptide and interleukin 6 in patients with mixed cryoglobulinemia 279
N-Terminal Pro-Brain Natriuretic Peptide and Tumor Necrosis Factor-alpha Both Are Increased in Patients With Hepatitis C 275
Clinical and subclinical autoimmune thyroid disorders insystemic sclerosis 273
Autoimmune and neoplastic thyroid diseases associated with hepatitis C chronic infection 272
Cytokines and HCV-related disorders 264
Modulatory effects of peroxisome proliferator-activated receptor-γ on CXCR3 chemokines 262
High circulating chemokines (C-X-C motif) ligand 9, and (C-X-C motif) ligand 11, in hepatitis C-associated cryoglobulinemia. 261
Application of Agents Against Interferon-Gamma-Dependent Chemokines in Immunotherapy 255
Induction of CXCL10 secretion by interferon-γ and tumour necrosis factor-α and its inhibition by peroxisome proliferator-activated receptor-γ agonists in cultured scleroderma fibroblasts. 254
Serum concentrations of interleukin 1beta, CXCL10, and interferon-gamma in mixed cryoglobulinemia associated with hepatitis C infection 251
Associations between Systemic Sclerosis and Thyroid Diseases 246
New targeted molecular therapies for dedifferentiated thyroid cancer 239
CXCL10 and CCL2 Chemokine Serum Levels in Patients With Hepatitis C Associated With Autoimmune Thyroiditis 231
Endocrine Manifestations of HCV-Positive Cryoglobulinemia 228
HEPATITIS C IS ASSOCIATED WITH HIGH LEVELS OF CIRCULATING N-TERMINAL PRO-BRAIN NATRIURETIC PEPTIDE AND INTERLEUKIN-6 222
Parallel increase of circulating CXCL11 and CXCL10 in mixed cryoglobulinemia, while the proinflammatory cytokine IL-6 is associated with high serum Th2 chemokine CCL2 217
High values of CXCL10 serum levels in mixed cryoglobulinemia associated with hepatitis C infection 217
IP-10 in autoimmune thyroiditis 216
Interferon-α, -β and -γ induce CXCL11 secretion in human thyrocytes: modulation by peroxisome proliferator-activated receptor γ agonists. 214
Novel Therapies for Thyroid Autoimmune Diseases 213
[CXCR3 and CXCL10 in autoimmune thyroiditis] 205
High Levels of Circulating Chemokine (C-X-C motif) Ligand 11 Are Associated with Euthyroid or Subclinically Hypothyroid Autoimmune Thyroiditis and with Chemokine (C-X-C Motif) Ligand 10 199
[Cryoglobulinemia and the α-chemokine IP-10] 199
Chemokine (CXC motif) ligand 9 serum levels in mixed cryoglobulinemia are associated with circulating levels of IFN-γ and TNF-α 197
The presence of autoimmune thyroiditis in mixed cryoglobulinemia patients is associated with high levels of circulating interleukin-6, but not of tumor necrosis factor-alpha. 196
Thyroid involvement in hepatitis C - associated mixed cryoglobulinemia 196
COVID-19 and systemic sclerosis: clinicopathological implications from Italian nationwide survey study 196
Incidence of thyroid disorders in mixed cryoglobulinemia: Results from a longitudinal follow-up 191
CXCL10 in psoriasis 190
PATIENTS WITH MIXED CRYOGLOBULINEMIA AND HCV INFECTION, IN PRESENCE OR ABSENCE OF AUTOIMMUNE THYROIDITIS, HAVE HIGH SERUM LEVELS OF (CXC MOTIF) LIGAND (CXCL)9 AND CXCL11 CHEMOKINES 188
RET TKI: potential role in thyroid cancers. 181
α-Chemokine CXCL10 and β-chemokine CCL2 serum levels in patients with hepatitis C-associated cryoglobulinemia in the presence or absence of autoimmune thyroiditis 178
Interleukin-1beta, C-X-C Motif Ligand 10, and Interferon-Gamma Serum Levels in Mixed Cryoglobulinemia With or Without Autoimmune Thyroiditis. 167
Increased CXCL9 serum levels in hepatitis C-related mixed cryoglobulinemia, with autoimmune thyroiditis, associated with high levels of CXCL10. 163
Role of CXCL10 in cryoglobulinemia 159
Extrahepatic manifestations of hepatitis C virus: the thyroid disorders 156
Systemic sclerosis fibroblasts show specific alterations of interferon-γ and tumor necrosis factor-α-induced modulation of interleukin 6 and chemokine ligand 2. 155
High serum levels of CXCL11 in mixed cryoglobulinemia are associated with increased circulating levels of interferon-γ. 153
Peroxisome proliferator-activated receptor γ agonists reduce cell proliferation and viability and increase apoptosis in systemic sclerosis fibroblasts 152
Type 1 diabetes and (C-X-C motif) ligand (CXCL) 10 chemokine 139
Immunomodulation of CXCL10 secretion by hepatitis C virus: Could CXCL10 be a prognostic marker of chronic hepatitis C? 136
Serum levels of proinflammatory cytokines interleukin-1beta, interleukin-6, and tumor necrosis factor alpha in mixed cryoglobulinemia 135
Increased risk of papillary thyroid cancer in systemic sclerosis associated with autoimmune thyroiditis 133
High circulating N-terminal pro-brain natriuretic peptide and tumor necrosis factor-alpha in mixed cryoglobulinemia 130
HCV-related autoimmune disorders in HCV chronic infection. 123
Mixed cryoglobulinemia and thyroid autoimmune disorders 112
Hepatitis C virus infection and type 2 diabetes. 101
Fatigue in patients with systemic sclerosis and hypothyroidism. A review of the literature and report of our experience 93
Totale 14.271
Categoria #
all - tutte 69.119
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 69.119


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021992 0 0 0 0 0 0 175 329 86 167 151 84
2021/20221.135 53 154 194 68 8 55 72 41 96 90 190 114
2022/2023980 153 76 81 74 151 139 19 103 110 7 45 22
2023/2024640 12 37 38 120 158 25 45 62 12 37 31 63
2024/20252.262 64 13 19 188 529 376 73 124 286 205 188 197
2025/20263.609 177 144 295 958 1.690 330 15 0 0 0 0 0
Totale 14.271